| - GRCh37:
- Chr2:215609790
- GRCh38:
- Chr2:214745066
| BARD1 | | Familial cancer of breast | Likely pathogenic (May 24, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr2:47630332
- GRCh38:
- Chr2:47403193
| MSH2 | M1K | Hereditary nonpolyposis colorectal neoplasms | Uncertain significance (Mar 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:48027385
- GRCh38:
- Chr2:47800246
| MSH6 | E453*, E580*, E625*, E656*, E699*, E729*, E755*, E757*, E787* | Stomach cancer | Pathogenic (Jul 1, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr2:47600704
- GRCh38:
- Chr2:47373565
| EPCAM | S60* | Stomach cancer | Pathogenic (Jul 1, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr2:47600600
- GRCh38:
- Chr2:47373461
| EPCAM | | Stomach cancer | Pathogenic (Jul 1, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr1:45805890
- GRCh38:
- Chr1:45340218
| MUTYH, TOE1 | | Stomach cancer | Pathogenic (Jul 1, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr1:45800111
- GRCh38:
- Chr1:45334439
| MUTYH | Q23*, Q29*, Q37* | Stomach cancer | Pathogenic (Jul 1, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr1:45798839
- GRCh38:
- Chr1:45333167
| MUTYH | W103*, W104*, W11*, W110*, W114*, W117*, W118*, W128*, W131*, W75* | Familial adenomatous polyposis 2 | Conflicting interpretations of pathogenicity (Dec 28, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:47601135
- GRCh38:
- Chr2:47373996
| EPCAM | R125* | Stomach cancer | Pathogenic (Jul 1, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr1:45797414
- GRCh38:
- Chr1:45331742
| MUTYH | E226*, E249*, E313*, E327*, E328*, E341*, E342*, E348*, E352*, E355*, E356*, E366*, E369* | Stomach cancer | Pathogenic (Jul 1, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr1:45795103
- GRCh38:
- Chr1:45329431
| MUTYH | K366*, K389*, K453*, K467*, K468*, K481*, K482*, K488*, K492*, K495*, K496*, K506*, K509* | Stomach cancer | Pathogenic (Jul 1, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr1:45795049
- GRCh38:
- Chr1:45329377
| MUTYH | Q384*, Q407*, Q471*, Q485*, Q486*, Q499*, Q500*, Q506*, Q510*, Q513*, Q514*, Q524*, Q527* | Stomach cancer | Pathogenic (Jul 1, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr17:59924582
- GRCh38:
- Chr17:61847221
| BRIP1 | | Stomach cancer | Pathogenic (Jul 1, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr17:59861674
- GRCh38:
- Chr17:61784313
| BRIP1 | G529* | Familial cancer of breast | Pathogenic (Jun 2, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr2:47596647
- GRCh38:
- Chr2:47369508
| EPCAM | M1I | Stomach cancer | Pathogenic (Jul 1, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr17:46804193
- GRCh38:
- Chr17:48726831
| HOXB13 | K272* | Stomach cancer | Pathogenic (Jul 1, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr11:108173722-108173736
- GRCh38:
- Chr11:108302995-108303009
| ATM | | Stomach cancer | Pathogenic (Jul 1, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr7:6043389
- GRCh38:
- Chr7:6003758
| PMS2 | F95fs | Stomach cancer | Pathogenic (Jul 1, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr22:29115398
- GRCh38:
- Chr22:28719410
| CHEK2 | | Stomach cancer | Pathogenic (Jul 1, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr22:29106014
- GRCh38:
- Chr22:28710026
| CHEK2 | I209fs, I276fs, I319fs, I55fs | Familial cancer of breast | Pathogenic (Jun 27, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr22:29099491
- GRCh38:
- Chr22:28703503
| CHEK2 | | Stomach cancer | Pathogenic (Jul 1, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr18:48593476-48593492
- GRCh38:
- Chr18:51067106-51067122
| SMAD4 | S411fs | Stomach cancer | Pathogenic (Jul 1, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr17:59934455-59934461
- GRCh38:
- Chr17:61857094-61857100
| BRIP1 | T113fs | Stomach cancer | Pathogenic (Jul 1, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr17:59876595
- GRCh38:
- Chr17:61799234
| BRIP1 | R403fs | Stomach cancer | Pathogenic (Jul 1, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr17:59770808
- GRCh38:
- Chr17:61693447
| BRIP1 | P853fs | Familial cancer of breast | Pathogenic (Jun 7, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr17:59761099-59761100
- GRCh38:
- Chr17:61683738-61683739
| BRIP1 | | Stomach cancer | Pathogenic (Jul 1, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr17:56801461
- GRCh38:
- Chr17:58724100
| RAD51C | | Stomach cancer | Pathogenic (Jul 1, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr2:47596645
- GRCh38:
- Chr2:47369506
| EPCAM | M1V | EPCAM-related condition | Likely pathogenic (Aug 29, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr17:46804162-46804163
- GRCh38:
- Chr17:48726800-48726801
| HOXB13 | A282fs | Stomach cancer | Pathogenic (Jul 1, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr17:41244447-41244448
- GRCh38:
- Chr17:43092430-43092431
| BRCA1 | N1034fs, N987fs, N1031fs, N906fs, N922fs, N964fs, N967fs, N992fs, N1033fs, N866fs, N963fs, N1008fs, N738fs, N923fs, N945fs, N966fs, N993fs, N1007fs, N907fs, N946fs, N986fs | Stomach cancer | Pathogenic (Jul 1, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr17:33433407
- GRCh38:
- Chr17:35106388
| RAD51D, RAD51L3-RFFL | Q192fs, Q212fs, Q80fs | Stomach cancer | Pathogenic (Jul 1, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr17:33428257
- GRCh38:
- Chr17:35101238
| RAD51D, RAD51L3-RFFL | G177fs, G289fs, G309fs | Stomach cancer | Pathogenic (Jul 1, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr17:33427985
- GRCh38:
- Chr17:35100966
| RAD51D, RAD51L3-RFFL | G213fs, G325fs, G345fs | Stomach cancer | Pathogenic (Jul 1, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr17:29663442
- GRCh38:
- Chr17:31336424
| NF1 | D2012fs, D2033fs | Stomach cancer | Pathogenic (Jul 1, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr17:29560190-29560208
- GRCh38:
- Chr17:31233172-31233190
| NF1 | I1223fs | Stomach cancer | Pathogenic (Jul 1, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr17:29559826-29559827
- GRCh38:
- Chr17:31232808-31232809
| NF1 | R1142fs | Stomach cancer | Pathogenic (Jul 1, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr16:23647258
- GRCh38:
- Chr16:23635937
| PALB2 | K203fs | Stomach cancer | Pathogenic (Jul 1, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr13:32914952-32914964
- GRCh38:
- Chr13:32340815-32340827
| BRCA2 | Y2154fs | Stomach cancer | Pathogenic (Jul 1, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr13:32914553-32914556
- GRCh38:
- Chr13:32340416-32340419
| BRCA2 | H2021fs | Stomach cancer | Pathogenic (Jul 1, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr13:32913030-32913033
- GRCh38:
- Chr13:32338893-32338896
| BRCA2 | D1513fs | Stomach cancer | Pathogenic (Jul 1, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr13:32912063
- GRCh38:
- Chr13:32337926
| BRCA2 | K1191fs | Stomach cancer | Pathogenic (Jul 1, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr13:32911970-32911971
- GRCh38:
- Chr13:32337833-32337834
| BRCA2 | D1161fs | Stomach cancer | Pathogenic (Jul 1, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr13:32911294
- GRCh38:
- Chr13:32337157
| BRCA2 | D935fs | Stomach cancer | Pathogenic (Jul 1, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr13:32911006-32911009
- GRCh38:
- Chr13:32336869-32336872
| BRCA2 | | Stomach cancer | Pathogenic (Jul 1, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr13:32910860
- GRCh38:
- Chr13:32336723
| BRCA2 | E790fs | Stomach cancer | Pathogenic (Jul 1, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr13:32907383
- GRCh38:
- Chr13:32333246
| BRCA2 | F590fs | Stomach cancer | Pathogenic (Jul 1, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr11:108201039-108201054
- GRCh38:
- Chr11:108330312-108330327
| ATM, C11orf65 | | Stomach cancer | Pathogenic (Jul 1, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr11:108178705-108178708
- GRCh38:
- Chr11:108307978-108307981
| ATM | Q1919fs | Stomach cancer | Pathogenic (Jul 1, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr11:108155126
- GRCh38:
- Chr11:108284399
| ATM | M1308fs | Stomach cancer | Pathogenic (Jul 1, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr11:108139221
- GRCh38:
- Chr11:108268494
| ATM | V908fs | Stomach cancer | Pathogenic (Jul 1, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr11:108126961
- GRCh38:
- Chr11:108256234
| ATM | V716fs | Stomach cancer | Pathogenic (Jul 1, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr11:108121537-108121538
- GRCh38:
- Chr11:108250810-108250811
| ATM | E450fs | Stomach cancer | Pathogenic (Jul 1, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr11:108121449
- GRCh38:
- Chr11:108250722
| ATM | I420fs | Stomach cancer | Pathogenic (Jul 1, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr11:108099988
- GRCh38:
- Chr11:108229261
| ATM | R90fs | Stomach cancer | Pathogenic (Jul 1, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr11:108099906
- GRCh38:
- Chr11:108229179
| ATM | L64fs | Stomach cancer | Pathogenic (Jul 1, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr10:89692768-89692769
- GRCh38:
- Chr10:87933011-87933012
| PTEN | | Stomach cancer | Pathogenic (Jul 1, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr8:90955493-90955497
- GRCh38:
- Chr8:89943265-89943269
| NBN | L641fs, L723fs | Stomach cancer | Pathogenic (Jul 1, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr5:112177109
- GRCh38:
- Chr5:112841412
| APC | I1657fs, I1780fs, I1814fs, I1839fs, I1849fs, I1881fs, I1899fs, I1912fs, I1915fs, I1922fs, I1940fs, I1950fs, I1958fs | Stomach cancer | Pathogenic (Jul 1, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr2:215646171-215646181
- GRCh38:
- Chr2:214781447-214781457
| BARD1 | K120fs, K139fs | Stomach cancer | Pathogenic (Jul 1, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr2:215645969
- GRCh38:
- Chr2:214781245
| BARD1 | T191fs, T210fs | Stomach cancer | Pathogenic (Jul 1, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr2:215645863
- GRCh38:
- Chr2:214781139
| BARD1 | Q226fs, Q245fs | Stomach cancer | Pathogenic (Jul 1, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr2:215645569
- GRCh38:
- Chr2:214780845
| BARD1 | S325fs, S344fs | Stomach cancer | Pathogenic (Jul 1, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr2:48033790
- GRCh38:
- Chr2:47806651
| MSH6 | | Stomach cancer | Pathogenic (Jul 1, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr2:48032121
- GRCh38:
- Chr2:47804982
| MSH6 | D1041fs, D1171fs, D869fs | Stomach cancer | Pathogenic (Jul 1, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr2:48027873
- GRCh38:
- Chr2:47800734
| MSH6 | H616fs, H788fs, H918fs | Stomach cancer | Pathogenic (Jul 1, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr13:32937344
- GRCh38:
- Chr13:32363207
| BRCA2 | R1025*, R2637*, R2669*, R530* | Stomach cancer | Pathogenic (Jul 1, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr2:47600692
- GRCh38:
- Chr2:47373553
| EPCAM | T56fs | Stomach cancer | Pathogenic (Jul 1, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr2:47600610-47600611
- GRCh38:
- Chr2:47373471-47373472
| EPCAM | | Stomach cancer | Pathogenic (Jul 1, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr2:47596681
- GRCh38:
- Chr2:47369542
| EPCAM | A14fs | Stomach cancer | Pathogenic (Jul 1, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr1:45805890
- GRCh38:
- Chr1:45340218
| MUTYH, TOE1 | | Stomach cancer | Pathogenic (Jul 1, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr1:45799167-45799168
- GRCh38:
- Chr1:45333495-45333496
| MUTYH | D61fs, D62fs, D72fs, D76fs, D86fs, D89fs | Hereditary cancer-predisposing syndrome | Pathogenic (Feb 14, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr22:29121089
- GRCh38:
- Chr22:28725101
| CHEK2 | | Stomach cancer | Pathogenic (Jul 1, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr17:59820450-59820453
- GRCh38:
- Chr17:61743089-61743092
| BRIP1 | E767fs | Stomach cancer | Pathogenic (Jul 1, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr17:41247930
- GRCh38:
- Chr17:43095913
| BRCA1 | Q155fs, Q202fs | Stomach cancer | Pathogenic (Jul 1, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr16:23647208
- GRCh38:
- Chr16:23635887
| PALB2 | S220fs | Stomach cancer | Pathogenic (Jul 1, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr13:32915109-32915112
- GRCh38:
- Chr13:32340972-32340975
| BRCA2 | T2207fs | Stomach cancer | Pathogenic (Jul 1, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr13:32914840
- GRCh38:
- Chr13:32340703
| BRCA2 | C2117fs | Stomach cancer | Pathogenic (Jul 1, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr13:32915148
- GRCh38:
- Chr13:32341011
| BRCA2 | S2219* | Stomach cancer | Pathogenic (Jul 1, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr13:32913380
- GRCh38:
- Chr13:32339243
| BRCA2 | S1630fs | Breast-ovarian cancer, familial, susceptibility to, 2 | Pathogenic (Jan 10, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr13:32911442
- GRCh38:
- Chr13:32337305
| BRCA2 | E984fs | Stomach cancer | Pathogenic (Jul 1, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr11:108186806
- GRCh38:
- Chr11:108316079
| ATM, C11orf65 | I2055fs | Stomach cancer | Pathogenic (Jul 1, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr2:215609790
- GRCh38:
- Chr2:214745066
| BARD1 | | Familial cancer of breast | Likely pathogenic (May 24, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr2:47596651
- GRCh38:
- Chr2:47369512
| EPCAM | P4fs | Stomach cancer | Pathogenic (Jul 1, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr22:29107975-29107976
- GRCh38:
- Chr22:28711987-28711988
| CHEK2 | E172fs, E18fs, E239fs, E282fs | Stomach cancer | Pathogenic (Jul 1, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr17:59934577-59934578
- GRCh38:
- Chr17:61857216-61857217
| BRIP1 | E74fs | Stomach cancer | Pathogenic (Jul 1, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr17:59763275-59763276
- GRCh38:
- Chr17:61685914-61685915
| BRIP1 | V943fs | Stomach cancer | Pathogenic (Jul 1, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr17:59760814-59760815
- GRCh38:
- Chr17:61683453-61683454
| BRIP1 | I1198fs | Stomach cancer | Pathogenic (Jul 1, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr17:56770117-56770118
- GRCh38:
- Chr17:58692756-58692757
| RAD51C | E40fs | Stomach cancer | Pathogenic (Jul 1, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr17:46804243-46804244
- GRCh38:
- Chr17:48726881-48726882
| HOXB13 | L255fs | not provided | Uncertain significance (Mar 16, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:46804231-46804232
- GRCh38:
- Chr17:48726869-48726870
| HOXB13 | Q259fs | Stomach cancer | Pathogenic (Jul 1, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr17:29563003-29563004
- GRCh38:
- Chr17:31235985-31235986
| NF1 | W1314fs | Stomach cancer | Pathogenic (Jul 1, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr17:7579378-7579379
- GRCh38:
- Chr17:7676060-7676061
| TP53 | Y103*, Y64* | Stomach cancer | Pathogenic (Jul 1, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr13:32914087-32914088
- GRCh38:
- Chr13:32339950-32339951
| BRCA2 | T1867fs | Stomach cancer | Pathogenic (Jul 1, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr12:58145064-58145065
- GRCh38:
- Chr12:57751281-57751282
| CDK4 | E94* | Stomach cancer | Pathogenic (Jul 1, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr11:108196794-108196795
- GRCh38:
- Chr11:108326067-108326068
| ATM, C11orf65 | A2274fs | Stomach cancer | Pathogenic (Jul 1, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr11:108175580
- GRCh38:
- Chr11:108304853
| ATM | | Stomach cancer | Pathogenic (Jul 1, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr11:108173631-108173632
- GRCh38:
- Chr11:108302904-108302905
| ATM | N1793fs | Stomach cancer | Pathogenic (Jul 1, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr11:108165754-108165755
- GRCh38:
- Chr11:108295027-108295028
| ATM | D1630fs | Stomach cancer | Pathogenic (Jul 1, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr11:108137984-108137985
- GRCh38:
- Chr11:108267257-108267258
| ATM | Q852fs | Stomach cancer | Pathogenic (Jul 1, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr10:89692885-89692886
- GRCh38:
- Chr10:87933128-87933129
| PTEN | C124fs, C297fs | Stomach cancer | Pathogenic (Jul 1, 2021) | no assertion criteria provided |